Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial.
Journal: Lancet (London, England)
Published: February 23, 2017
An Overview of Quadrivalent Human Papillomavirus Vaccine Safety: 2006 to 2015.
Journal: The Pediatric infectious disease journal
Published: June 25, 2015
Development of a human papillomavirus competitive luminex immunoassay for 9 HPV types.
Journal: Human vaccines & immunotherapeutics
Published: November 27, 2014
Incidence, clearance, and disease progression of genital human papillomavirus infection in heterosexual men.
Journal: The Journal of infectious diseases
Published: February 06, 2014
Proximity of first sexual intercourse to menarche and risk of high-grade cervical disease.
Journal: The Journal of infectious diseases
Published: October 16, 2012
Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data.
Journal: BMJ (Clinical research ed.)
Published: March 29, 2012
Clinical trial experience with prophylactic human papillomavirus 6/11/16/18 vaccine in young black women.
Journal: The Journal of adolescent health : official publication of the Society for Adolescent Medicine
Published: February 22, 2012
Immunogenicity of the quadrivalent human papillomavirus (type 6/11/16/18) vaccine in males 16 to 26 years old.
Journal: Clinical and vaccine immunology : CVI
Published: December 14, 2011
HPV vaccine against anal HPV infection and anal intraepithelial neoplasia.
Journal: The New England journal of medicine
Published: October 28, 2011
Showing 1-11 of 11
Last Updated: 09/26/2026